Laparoscopic Versus Robotic Lateral Transabdominal Adrenalectomy
Launched by THE CLEVELAND CLINIC · May 6, 2024
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two types of surgery for removing adrenal tumors: laparoscopic surgery and robotic surgery. Both methods are considered standard treatments, and the goal of the study is to see how well each method works for patients and how efficiently surgeons can perform them. By gathering information from this study, the researchers hope to improve patient care and outcomes in adrenal surgery.
To be eligible for this trial, participants should be men and women aged 18 to 75 who have been diagnosed with an adrenal tumor and are scheduled for a minimally invasive surgery at the Cleveland Clinic. Certain individuals may not qualify, such as those needing more extensive surgery or those with specific health concerns. If eligible, participants can expect to receive either laparoscopic or robotic surgery, and they will help researchers understand which method may be better for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Men and women between ages 18 and 75
- • 2. Diagnosis of an adrenal tumor/pathology planned for a minimally invasive adrenalectomy at the department of endocrine surgery at the Cleveland Clinic.
- Exclusion Criteria:
- • 1. Requirement for an open adrenalectomy based on imaging studies suggesting an aggressive cancer.
- • 2. The presence of extensive surgical history precluding a minimally invasive approach to be undertaken.
- • 3. Patients planned for a partial, rather than a complete adrenalectomy, as the former is a much easier procedure.
- • 4. Patients planned for a posterior adrenalectomy (these would be patients with an extensive surgical history with significant intra-abdominal adhesions and those requiring bilateral adrenalectomy).
- • 5. Mental incapacity or language barrier
- • 6. Any condition, unwillingness, or inability, not covered by any of the other exclusion criteria, which, in the study clinician's opinion, might jeopardize the subject's safety or compliance with the protocol
About The Cleveland Clinic
The Cleveland Clinic is a renowned nonprofit academic medical center based in Cleveland, Ohio, recognized for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, the Cleveland Clinic leverages its multidisciplinary expertise and state-of-the-art facilities to conduct groundbreaking studies aimed at improving patient outcomes across a wide range of medical conditions. With a strong emphasis on patient-centered care, the institution fosters collaboration among researchers, clinicians, and patients to explore new treatments and therapies, contributing significantly to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Patients applied
Trial Officials
Eren Berber, MD
Principal Investigator
The Cleveland Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported